MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill with imprint MYLAN 2045 MYLAN 2045 is Orange / Gray, Capsule-shape and has been identified as Tacrolimus 0.5 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; crohn's disease; graft-versus-host disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for MYLAN 2045 MYLAN 2045

Save up to 80% off prescription medications

Click here for your free Discount Card

Tacrolimus

Imprint:

MYLAN 2045 MYLAN 2045

Strength:

0.5 mg

Color:

Orange / Gray

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Calcineurin inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
gelatin
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
D&C Red No. 28
D&C Yellow No. 10
FD&C Red No. 40
FD&C Blue No. 1
FD&C Blue No. 2
propylene glycol
shellac
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
51079-0817	UDL Laboratories Inc.

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.